Polaryx Therapeutics

(NASDAQ) PLYX

Current Price$3.59

Market Cap$186.53M

Since IPO (2026)-89%

5 YearN/A

1 YearN/A

1 Month-25%

Polaryx Therapeutics Financials at a Glance

Market Cap

$186.53M

Revenue (TTM)

$0.00

Net Income (TTM)

$6.48M

EPS (TTM)

$-0.14

P/E Ratio

-28.78

Dividend

$0.00

Beta (Volatility)

0.37 (Low)

Dividend

$0.00

Beta (Volatility)

0.37 (Low)

Price

$3.59

Volume

5,383

Open

$4.09

Price

$3.59

Volume

5,383

Open

$4.09

Previous Close

$3.59

Daily Range

$3.54 - $4.09

52-Week Range

$2.20 - $48.91

Dividend

$0.00

Beta (Volatility)

0.37 (Low)

Price

$3.59

Volume

5,383

Open

$4.09

Previous Close

$3.59

Daily Range

$3.54 - $4.09

52-Week Range

$2.20 - $48.91

PLYX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Polaryx Therapeutics

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Alex Yang

Website

www.polaryx.com

Headquarters

Paramus, NJ 07652, US

PLYX Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-192%

Return on Capital

-2%

Return on Assets

-2%

Earnings Yield

-3.47%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$186.53M

Shares Outstanding

47.34M

Volume

5.38K

Avg. Volume

905.50K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$7.82M

EBITDA

$7.82M

Operating Cash Flow

$3.94M

Capital Expenditure

$0.00

Free Cash Flow

$3.94M

Cash & ST Invst.

$5.14M

Total Debt

$0.00

Polaryx Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$186.53M

N/A

Market Cap/Employee

$16.96M

N/A

Employees

N/A

Net Income

$2.54M

+49.6%

EBITDA

$1.96M

+61.2%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$3.08M

-26.0%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-1.85%

N/A

Return on Invested Capital

-1.90%

N/A

Free Cash Flow

$1.49M

N/A

Operating Cash Flow

$1.49M

N/A

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ANTXAN2 Therapeutics, Inc.

ANTXAN2 Therapeutics, Inc.$4.85-0.82%

FHTXFoghorn Therapeutics Inc.

FHTXFoghorn Therapeutics Inc.$4.22+1.44%

KLRSKalaris Therapeutics Inc

KLRSKalaris Therapeutics Inc$4.92-3.91%

KZRKezar Life Sciences, Inc.

KZRKezar Life Sciences, Inc.$7.29+0.00%

NXTCNextCure, Inc.

NXTCNextCure, Inc.$7.83-22.55%

HCWBHCW Biologics Inc.

HCWBHCW Biologics Inc.$2.89+12.02%

LYELLyell Immunopharma, Inc.

LYELLyell Immunopharma, Inc.$17.46+0.92%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$13.85+0.02%

NIONio

NIONio$5.20-0.07%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.26+0.04%

INFQInfleqtion

INFQInfleqtion $16.35+0.11%

TET1 Energy Inc.

TET1 Energy Inc.$8.08-0.07%

FUTUFutu

FUTUFutu$89.76-0.28%

ONDSOndas

ONDSOndas$9.06-0.01%

Questions About PLYX

What is the current price of Polaryx Therapeutics?

Polaryx Therapeutics is trading at $3.59 per share.

What is the 52-week range for Polaryx Therapeutics?

Over the past 52 weeks, Polaryx Therapeutics has traded between $2.20 and $48.91.

How much debt does Polaryx Therapeutics have?

As of the most recent reporting period, Polaryx Therapeutics reported total debt of N/A.

How much cash does Polaryx Therapeutics have on hand?

Polaryx Therapeutics reported $3.08M in cash and cash equivalents in its most recent financial results.

What is Polaryx Therapeutics’s dividend yield?

Polaryx Therapeutics does not currently have a dividend yield.

Polaryx Therapeutics

Polaryx Therapeutics Financials at a Glance

PLYX News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Polaryx Therapeutics

PLYX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Polaryx Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About PLYX

What is the current price of Polaryx Therapeutics?

What is the 52-week range for Polaryx Therapeutics?

How much debt does Polaryx Therapeutics have?

How much cash does Polaryx Therapeutics have on hand?

What is Polaryx Therapeutics’s dividend yield?

Premium Investing Services